Morphologic alterations in rat brain following systemic and intraventricular methotrexate injection: light and electron microscopic studies.
To determine the morphological substrate of acute methotrexate (MTX) encephalopathy, light and electron microscopic studies were performed on rat brains after short-term intraperitoneal (IP) and intraventricular (IV) injections of MTX. In both models, Alzheimer type II astrocytosis was the initial and major pathologic alteration seen by light microscopy. The neurons, oligodendrocytes, myelin and endothelial cells were relatively spared. Ultrastructural studies showed pleomorphism and condensation of mitochondria, membrane-bound vacuoles, prominent stacks of sparsely granular, rough endoplasmic reticulum and progressive hydropic swelling of astrocytic perikarya and their processes. The astroglial alterations were reversible after cessation of the drug but persisted for a longer time with repeated IP administration. Gastrointestinal complications and overall mortality were also greater with higher doses and increasing frequency of IP MTX injection. White matter necrosis was noted only after IV injection of high-dose MTX. The neuropathologic changes of MTX leukoencephalopathy can be replicated in an animal model by IV injection of the drug. The reversibility of the changes that were seen following IP administration correlates with the transient neurologic deficits observed in some patients after high-dose systemic MTX therapy. The initially selective astroglial effect suggests that astrocytes might be a target for MTX toxicity, although other central nervous system components may also be adversely affected by the drug.
Gregorios
J B
JB
Laboratory of Neuropathology, University of Miami, Jackson Memorial Hospital, Florida.
Gregorios
A B
AB
Mora
J
J
Marcillo
A
A
Fojaco
R M
RM
Green
B
B
D000544:Alzheimer Disease / Q000473:pathology; D000818:Animals; D001921:Brain / Q000166:cytology* / Q000648:ultrastructure; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D008854:Microscopy, Electron; D051381:Rats; D011919:Rats, Inbred Strains
D008727:Methotrexate